Nussenzweig and colleagues evaluate genomic instability and germinal center derived lymphomagenesis in mice infected with Plasmodium to recreate some of the hallmark characteristics of Burkitt lymphoma, a form of cancer more common in parts of Africa where malaria is endemic.
The DNA mutator activation-induced cytosine deaminase (AID) is critical for antibody affinity maturation by creating nicks and double strand breaks (DSBs) during the processes of class switch recombination (CSR) and somatic hypermutation. However, problems arise when this activity becomes promiscuous, targeting non-immunoglobulin gene (nonIg) locations in the B cell genome (Liu and Schatz, 2009 ). These non-Ig mutations can lead to the ligation of inappropriate segments of chromosomes, causing expression of oncogenes or repression of tumor-suppressors, ultimately leading to fatal malignancies (summarized in Robbiani and Nussenzweig, 2013) Most studies correlating AID's DNA mutator activity with chromosomal translocations have been performed with artificial systems of AID misregulation or via immune responses elicited by experimental means in the laboratory. Thus, an experimental system for B cell induction in a pathologically relevant infectious disease model has been lacking. In the Robbiani et al. (2015) paper published in this issue of Cell, the laboratory of Michel Nussenzweig has linked B cell genome mutagenesis by AID to the real world problem of Plasmodium infection and its connection with endemic Burkitt lymphoma in equatorial Africa and New Guinea.
Burkitt lymphoma is an aggressive nonHodgkin lymphoma, first described in detail by Denis Burkitt in 1958 at the Mulago hospital in Uganda. It is a B cell malignancy occurring most frequently in children in areas with endemic malaria, and with lower frequencies in all other parts of the world. The connection between the level of malaria infection and the number of cases is striking (Magrath, 2012) . When malaria was successfully eradicated from the Zanzibar islands off the coast of Tanzania, Burkitt lymphoma disappeared; when the eradication program for malaria was halted, cases reappeared. In areas of endemic malaria, Burkitt lymphoma is characterized by tumors affecting most frequently the jaw and facial bones, while sporadic cases (areas outside endemic malarial infection) frequently present with tumors in the gut and upper respiratory tract. Whether endemic or sporadic, there is an almost 100% correlation between diagnosis and a reciprocal chromosomal translocation involving the proto-oncogene MYC on chromosome 8 and one of the Ig gene heavy or light chain loci on chromosomes 14, 2, or 22 (Boxer and Dang, 2001) .
Infecting mice with Plasmodium chabaudi (a rodent-specific species that may display characteristics distinct from the human infectious agent Plasmodium falciparum), Robbiani and colleagues model endemic Burkitt lymphoma. To summarize succinctly their findings, Plasmodium infection induces a robust and long-lasting expansion of germinal center B cells, AID expression is restricted to these cells and sustained at high levels over a period of at least 10 weeks following infection, and widespread chromosomal translocations are found in malaria-infected germinal center B cells (schematized for potential human equivalent in Figure 1 ). The latter finding is observed through a sophisticated set of experiments using the translocation capture-sequencing technique (Klein et al., 2011) . The authors experimentally link the rapid onset of AID expression in germinal center B cells to the spectrum of translocation events and the type of lymphomagenesis. Finally, they test the role of AID and p53 in the development of lymphomas in their malaria model in which one infected cohort is wild-type (expresses both p53 and AID), one lacks p53 but has AID, and one lacks both p53 and AID. The first group develops no tumors, the second group uniformly develops lymphomas that are mostly mature and consistent with germinal center origin (a sign of AID-induced tumorigenesis), and the final group develops mainly benign splenomegaly (67%) with only a small number of animals developing lymphomas. Basically, if mice are infected with Plasmodium and are p53 À ; AID + they will develop lymphomas, but if they are p53 À ; AID À lymphoma will develop in rare cases but other malarial infection phenotypes will occur as expected. The widespread genomic instability in these malaria germinal center B cells can be localized to previously identified regions of AID-dependent mutagenesis as well as to regions prone to DNA breakage referred to as early replication fragile sites (Figure 1, right) . Thus, it is possible that germinal center B cells in malaria may provide a patho-physiological model for AID-independent DNA rearrangement in the context of a germinal center reaction. The reader may wonder how the malaria parasite targets the germinal center. The Toll like receptors (TLRs), found on mature B cells, are able to activate AID. TLR agonists include hemozoin, a byproduct of hemoglobin digestion by Plasmodium, and CpG enriched DNA found in many microorganisms (Magrath, 2012) . Thus, Plasmodium infection has the potential to engage pathways that directly activate AID in the germinal center. Taken together, in the context of distribution and mechanism of translocations and pathways that activate AID expression, there are numerous opportunities for exciting future studies. However, it must be noted that the mice of Robbiani et al. do not recapitulate the human features of the disease in every detail (tumor location and histopathology are different, for example.) This distinction needs to be considered cautiously.
We have recently progressed in our understanding of the various mechanisms that can promote AID-induced chromosomal translocations. Specifically, antisense transcription at divergently transcribed enhancer sites and genic transcription start sites sometimes overlaps with translocations (Pefanis et al., 2014; Pefanis et al., 2015) , particularly in the context of convergence of the RNA pol II complex (Meng et al., 2014) . Moreover, these AID-induced translocation sites are enriched inside topologically defined super-enhancer domains, themselves enriched in enhancer-promoter interactions (Qian et al., 2014) . The naturally occurring question, then, is: do all these chromosomal translocation mechanics apply in malaria germinal center cells and can we discover additional information from this enticing system? How do translocations occur at early replication fragile sites, and what biological parameters do they follow that prevents them from causing robust tumorigenesis? Indeed, Robbiani's paper is a very interesting study that raises many new questions and provides the B cell field an opportunity to contribute further to the understanding of pathological conditions that are challenges in global healthcare. 
. From Mosquito to Lymphoma
Depicted is a schematic of Plasmodium infection leading to B cell genomic instability and AID-mediated IgH-myc translocation in humans, extrapolated from the study of Robbiani et al. (2015) . A female mosquito infects the human host, releasing the infective malarial sporozoite, which travels through the blood to the liver, where it reproduces, infecting red blood cells and ultimately lysing them. Hemozoin, a product of the trophozoite feeding on (and lysing) red blood cells, activates Toll-like receptors on the surface of lymphocytes found within the dark zone of the germinal center. Activation of the Toll-like receptor causes B cell hyperplasia and activation of AID beyond AID's normal roles in class switch recombination and somatic hypermutation, causing breakage and rejoining in sites previously identified as AID targets as well as in locations within early replication fragile sites. The AID targets in Burkitt lymphoma involve rejoining of the heavy and light chain loci in the immunoglobulin loci with the proto-oncogene c-myc.
